Oxford Begins First Human Trials for Bundibugyo Ebola Vaccine
The University of Oxford has commenced its first-in-human clinical trial for a vaccine targeting the Bundibugyo ebolavirus. This Phase I study aims to evaluate the safety and immunogenicity of the ... Read More